Schedule 13G ownership disclosure

COGENT BIOSCIENCES INC

Common Stock, $0.001 par value per share · CUSIP: 19240Q201

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Paradigm BioCapital Advisors LP

    Shares: 10,352,449.00 · Class: 9.1%

  • Paradigm BioCapital Advisors GP LLC

    Shares: 10,352,449.00 · Class: 9.1%

  • Senai Asefaw, M.D.

    Shares: 10,352,449.00 · Class: 9.1%

  • Paradigm BioCapital International Fund Ltd.

    Shares: 9,169,832.00 · Class: 8.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-078669
Form type
SCHEDULE 13G/A
Filer
Cogent Biosciences, Inc.
CIK
CIK 1622229
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub